Ferrante M - Search Results

1

2020 international consensus on ANCA testing beyond systemic vasculitis.

Moiseev S, Cohen Tervaert JW, Arimura Y, Bogdanos DP, Csernok E, Damoiseaux J, Ferrante M, Flores-Suárez LF, Fritzler MJ, Invernizzi P, Jayne D, Jennette JC, Little MA, McAdoo SP, Novikov P, Pusey CD, Radice A, Salama AD, Savige JA, Segelmark M, Shoenfeld Y, Sinico RA, Sousa MJ, Specks U, Terrier B, Tzioufas AG, Vermeire S, Zhao MH, Bossuyt X. Moiseev S, et al. Among authors: ferrante m. Autoimmun Rev. 2020 Sep;19(9):102618. doi: 10.1016/j.autrev.2020.102618. Epub 2020 Jul 12. Autoimmun Rev. 2020. PMID: 32663621 Review.

2

Protein-losing enteropathy in Crohn's disease.

Ferrante M, Penninckx F, De Hertogh G, Geboes K, D'Hoore A, Noman M, Vermeire S, Rutgeerts P, Van Assche G. Ferrante M, et al. Acta Gastroenterol Belg. 2006 Oct-Dec;69(4):384-9. Acta Gastroenterol Belg. 2006. PMID: 17343081

3

Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.

Henckaerts L, Pierik M, Joossens M, Ferrante M, Rutgeerts P, Vermeire S. Henckaerts L, et al. Among authors: ferrante m. Gut. 2007 Nov;56(11):1536-42. doi: 10.1136/gut.2007.125468. Epub 2007 Jun 26. Gut. 2007. PMID: 17595233 Free PMC article.

4

Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.

Ferrante M, Declerck S, De Hertogh G, Van Assche G, Geboes K, Rutgeerts P, Penninckx F, Vermeire S, D'Hoore A. Ferrante M, et al. Inflamm Bowel Dis. 2008 Jan;14(1):20-8. doi: 10.1002/ibd.20278. Inflamm Bowel Dis. 2008. PMID: 17973304

5

Optimizing biologic therapies for inflammatory bowel disease (ulcerative colitis and Crohn's disease).

Ferrante M, D'Haens G, Rutgeerts P, Vermeire S, Van Assche G. Ferrante M, et al. Curr Gastroenterol Rep. 2009 Dec;11(6):504-8. doi: 10.1007/s11894-009-0076-5. Curr Gastroenterol Rep. 2009. PMID: 19903427 Review.

6

Reply to Dr. Caprilli et al.'s letter.

Ferrante M, Vermeire S, Van Assche G, Rutgeerts P. Ferrante M, et al. J Crohns Colitis. 2009 Feb;3(1):45. doi: 10.1016/j.crohns.2008.11.001. Epub 2008 Dec 5. J Crohns Colitis. 2009. PMID: 21172249 No abstract available.

7

Tolerability of shortened infliximab infusion times in patients with inflammatory bowel diseases: a single-center cohort study.

Breynaert C, Ferrante M, Fidder H, Van Steen K, Noman M, Ballet V, Vermeire S, Rutgeerts P, Van Assche G. Breynaert C, et al. Among authors: ferrante m. Am J Gastroenterol. 2011 Apr;106(4):778-85. doi: 10.1038/ajg.2011.61. Epub 2011 Mar 15. Am J Gastroenterol. 2011. PMID: 21407184

8

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy.

Schnitzler F, Fidder H, Ferrante M, Ballet V, Noman M, Van Assche G, Spitz B, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Schnitzler F, et al. Among authors: ferrante m. Inflamm Bowel Dis. 2011 Sep;17(9):1846-54. doi: 10.1002/ibd.21583. Epub 2011 Jan 6. Inflamm Bowel Dis. 2011. PMID: 21830263

9

Certolizumab pegol in the treatment of Crohn's disease.

Ferrante M, Vermeire S, Rutgeerts P. Ferrante M, et al. Expert Opin Biol Ther. 2013 Apr;13(4):595-605. doi: 10.1517/14712598.2013.777039. Epub 2013 Mar 4. Expert Opin Biol Ther. 2013. PMID: 23451881 Review.

10

Anxiety is associated with impaired tolerance of colonoscopy preparation in inflammatory bowel disease and controls.

Bessissow T, Van Keerberghen CA, Van Oudenhove L, Ferrante M, Vermeire S, Rutgeerts P, Van Assche G. Bessissow T, et al. Among authors: ferrante m. J Crohns Colitis. 2013 Dec;7(11):e580-7. doi: 10.1016/j.crohns.2013.04.011. Epub 2013 May 9. J Crohns Colitis. 2013. PMID: 23664621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

928 results

Search Page